Kurt Schrader: “Selling these assets would just fragment the grid, cause national security issues.”

The success that WRDA has had during these divided times is a testament to the committee's willingness to work across the aisle.

I am hopeful that the committee's work here will build on that success to tackle the many backlogged projects that are sadly still unfunded even with increased investments.

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

I want that to occur in America. I want it to occur in the districts that some of these members in this room represent, and I think we found that balance.